Simvastatin Alleviation of Trimethyltin‐Induced Hippocampal and Behavioral Impairments via Improvement of Antioxidants, Mitochondrial Health, and Energy Homeostasis
Pharmacology Research & Perspectives · 2026-12 · 14 (6)
DOI: 10.1002/prp2.70352 ↗At a glance
Journal article in Pharmacology Research & Perspectives, published online on 2026-11-15. Written by Adel Salari and 3 co-authors. Institution: Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. Major MEDLINE topics: Simvastatin, Hippocampus, Antioxidants, Mitochondria. 72 references. The full text is freely available (open access, CC BY 4.0). Funded by: Shahed University.
Abstract (original language)
Mitochondrial dysfunction and antioxidant deficiency are key contributors to the pathogenesis of Alzheimer's disease (AD). Trimethyltin (TMT) induces selective hippocampal damage associated with redox disequilibrium, neuroinflammatory responses, mitochondrial dysfunction, and impaired energy homeostasis, leading to cognitive decline. The present study evaluated whether simvastatin as a lipid‐lowering and protective medicine could mitigate TMT‐induced behavioral abnormalities by improving hippocampal antioxidant status, mitochondrial integrity, and energy homeostasis. Rats were assigned to control, control + simvastatin (30 mg/kg), TMT, TMT + simvastatin (10 mg/kg), and TMT + simvastatin (30 mg/kg) groups. TMT was injected IP (once, 8 mg/kg) to instigate neurotoxicity. Following three weeks of treatment, locomotor activity and conditioned learning and memory deficits were analyzed using open‐field and passive avoidance tests, respectively. Besides, hippocampal levels or activity of nitrite, glutathione (GSH), glutathione peroxidase (GPx), myeloperoxidase (MPO), and β‐site APP‐cleaving enzyme 1 (BACE1), mitochondrial membrane potential (MMP), and AMP‐activated protein kinase (AMPK) were measured. Simvastatin treatment (30 mg/kg) was associated with higher latency in the passive avoidance test and longer rearing in the open field test in TMT‐intoxicated rats. Additionally, simvastatin improved hippocampal GSH, GPx, MMP, and AMPK and mitigated MPO activity relative to the TMT group but did not significantly affect nitrite or BACE‐1 activity. Collectively, simvastatin mitigated TMT‐induced neurobehavioral impairment, partly through restoration of antioxidants and mitochondrial health in association with AMPK.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
- Neurophysiology Research Center, Shahed University, Tehran, Iran.
ORCID profiles: Adel Salari, Mahdieh Taheri, Mohsen Khalili, Mehrdad Roghani
Funding
- Shahed University
Cite
APA
Salari, A., Taheri, M., Khalili, M., & Roghani, M. (2026). Simvastatin Alleviation of Trimethyltin‐Induced Hippocampal and Behavioral Impairments via Improvement of Antioxidants, Mitochondrial Health, and Energy Homeostasis. Pharmacology Research & Perspectives, 14(6). https://doi.org/10.1002/prp2.70352
Vancouver
Salari A, Taheri M, Khalili M, Roghani M. Simvastatin Alleviation of Trimethyltin‐Induced Hippocampal and Behavioral Impairments via Improvement of Antioxidants, Mitochondrial Health, and Energy Homeostasis. Pharmacology Research & Perspectives. 2026;14(6). doi:10.1002/prp2.70352
BibTeX
@article{Salari2026,
author = {Salari, Adel and Taheri, Mahdieh and Khalili, Mohsen and Roghani, Mehrdad},
title = {Simvastatin Alleviation of Trimethyltin‐Induced Hippocampal and Behavioral Impairments via Improvement of Antioxidants, Mitochondrial Health, and Energy Homeostasis},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {6},
doi = {10.1002/prp2.70352}
}
EUVIMED